Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mohamed Hbibi1, Mounira El Alaoui El Hanafi2, Zakaria Kasmi3

  • 1Department of hematology-Oncology pediatric SHOP, Hassan II University Hospital, Fez, Morocco.

La Tunisie Medicale
|March 28, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent Pelvic Lipoblastoma With Sciatic Nerve Compression in an Infant: A Case Report.

Cureus·2026
Same author

Fatal Presumed Rhino-Orbito-Sinus Mucormycosis in a Child With Fanconi Anemia: A Case Report.

Cureus·2026
Same author

The prevalence and associated factors with burnout among healthcare workers in Morocco: A systematic review.

La Tunisie medicale·2026
Same author

Arabic Translation and Adaptation of the CVID_QoL Questionnaire to Measure Health-RelatedQuality of Life of Adultswith Common Variable Immune Deficiency.

La Tunisie medicale·2026
Same author

Role of High-Sensitivity Troponins in Cardiovascular Risk Assessment in Asymptomatic Adults: A Systematic Review [cite: 3].

La Tunisie medicale·2026
Same author

STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy.

Journal of human immunity·2026
Same journal

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same journal

Pharmacological evaluation of anti-inflammatory potential and antispasmodic effect of aqueous extract from the brown seaweed, Cystoseira compressa.

La Tunisie medicale·2026
Same journal

Assessing the Accuracy of LDL-Cholesterol Estimation Formulas in the Tunisian Population.

La Tunisie medicale·2026
Same journal

Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters.

La Tunisie medicale·2026
Same journal

Association between Oxidative Stress, Cardiovascular Risk, and Disease Activity in Patients with Spondyloarthritis: A Cross-Sectional Study in a Tunisian Cohort.

La Tunisie medicale·2026
Same journal

Assessment of oral cancer awareness among dentists in Tunisia: A cross-sectional study.

La Tunisie medicale·2026
See all related articles
This summary is machine-generated.

Autoimmune cytopenias, like Evans syndrome, can signal underlying primary immunodeficiencies (IEI). Early diagnosis of IEI is crucial for effective treatment, especially in chronic or refractory cases.

Area of Science:

  • Immunology
  • Hematology

Context:

  • Autoimmune cytopenias involve autoantibody-mediated destruction of blood cells.
  • Evans syndrome, characterized by autoimmune hemolytic anemia and/or immune thrombocytopenia, can be secondary to infections or other conditions.
  • Primary immunodeficiencies (IEI) are increasingly recognized for autoimmune manifestations beyond infections.

Purpose:

  • To highlight the significance of autoimmune cytopenias as potential indicators of primary immunodeficiencies.
  • To emphasize the diagnostic challenges posed by chronic, recurrent, or refractory autoimmune cytopenias.
  • To advocate for timely diagnosis of IEI to guide targeted therapy and avoid ineffective treatments.

Summary:

  • Autoimmune cytopenias, including Evans syndrome, are often linked to primary immunodeficiencies (IEI).
Keywords:
AutoimmunityEvans SyndromeHumanIEILeukopeniaPurpuraThrombocytopenia

Related Experiment Videos

  • These conditions can present with chronic or refractory autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP).
  • Recognizing IEI is critical for initiating specific treatments and improving patient outcomes.

    • Impact:

    • Facilitates earlier diagnosis of primary immunodeficiencies (IEI).
    • Improves management strategies for patients with chronic or refractory autoimmune cytopenias.
    • Reduces the use of ineffective immunosuppressive therapies by identifying underlying IEI.